This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
8 JM Bourre , A Faivre , O Dumont , A Nouvelot , C L'Oudes , J Puymirat & A Tixier-Vidal (1983) Effect of polyunsaturated fatty acids on fetal mouse brain cells in culture in a chemically defined medium. J Neurochem 41, 1234–1242.
9 JM Bourre , G Pascal , G Durand , M Masson , O Dumont & M Piciotti (1984) Alterations in the fatty acid composition of rat brain cells (neurons, astrocytes, and oligodendrites) and of subcellular fractions (myelin and synaptosomes) induced by a diet devoid of n-3 fatty acids. J Neurochem 43, 342–348.
10 W Ehringer , D Belcher , SR Wassall & W Stillwell (1990) A comparison of the effects of linolenic acid (18:3Ω3) and docosahexaenoic (22:6Ω3) acids on phospholipid bilayers. Chem Phys Lipids 54, 79–88.
12 F Hirashima , AM Parow , AL Stoll , CM Demopulos , KE Damico , ML Rohan , JG Eskesen , CS Zuo , BM Cohen & PF Renshaw (2004) Omega-3 fatty acid treatment and T2 whole brain relaxation times in bipolar disorder. Am J Psychiatry 161, 1922–1924.
15 S Delion , S Chalon , D Guilloteau , JC Besnard & G Durand (1996) α-Linolenic acid dietary deficiency alters age related changes in dopaminergic and serotinergic neurotransmission in the rat frontal cortex. J Neurochem 66, 1582–1591.
17 T Takeuchi , Y Fukumoto & E Harada (2002) Influence of a dietary n-3 fatty acid deficiency on the cerebral catecholamine contents, EEG and learning ability in rat. Behav Brain Res 131, 193–203.
20 K Hamazaki , M Itomura , M Huan , H Nishizawa , S Sawazaki , M Tanouchi , S Watanabe , T Hamazaki , K Terasawa & K Yazawa (2005) Effects of omega-3 fatty acid-containing phospholipids on blood catecholamine concentrations in healthy volunteers: a randomized, placebo controlled, double blind trial. Nutrition 21, 705–710.
21 S Sawazaki , T Hamazaki , K Yazawa & M Kobayashi (1999) The effect of docosahexaenoic acid on plasma catecholamine concentrations and glucose tolerance during long-lasting psychological stress: a double blind placebo controlled study. J Nutr Sci Vitaminology 45, 655–665.
22 PC Calder (2003) n-3 Polyunsaturated fatty acids and inflammation: from molecular biology to the clinic. Lipids 38, 342–352.
23 JK Yao , CG Sistilli & DP van Kammen (2003) Membrane polyunsaturated fatty acids and CSF cytokines in patients with schizophrenia. Prostaglandins Leukot Essent Fatty Acids 69, 429–436.
25 LS Rallidis , G Paschos , GK Liakos , AH Velissaridou , G Anastasiadis & A Zampelas (2003) Dietary α-linolenic acid decreases C-reactive protein, serum amyloid A and interleukin-6 in dyslipidaemic patients. Atherosclerosis 167, 237–242.
28 A Ahmad , T Moriguchi & N Salem (2002) Decrease in neuron size in docosahexaenoic acid-deficient brain. Pediatr Neurol 26, 210–218.
29 A Ikemoto , A Nitta , S Furukawa , M Ohishi , A Nakamura , Y Fujii & H Okuyama (2000) Dietary n-3 fatty acid deficiency decreases nerve growth factor content in rat hippocampus. Neurosci Lett 285, 99–102.
31 RS Smith (1991) The macrophage theory of depression. Med Hypotheses 35, 298–306.
32 DF Horrobin (1998) The membrane phospholipid hypothesis as a biochemical basis for the neurodevelopmental concept of schizophrenia. Schizophr Res 30, 193–208.
34 JR Hibbeln (1998) Fish consumption and major depression. Lancet 351, 1213.
35 MM Weissman , RC Bland , GJ Canino , . (1996) Cross-national epidemiology of major depression and bipolar disorder. JAMA 276, 293–299.
36 JR Hibbeln (2002) Seafood consumption, the DHA content of mother's milk and prevalence rates of postpartum depression: a cross-national, ecological analysis. J Affect Dis 69, 15–29.
39 M Peet (2004) International variations in the outcome of schizophrenia and the prevalence of depression in relation to national dietary practices: an ecological analysis. Br J Psychiatry 184, 404–408.
41 A Tanskanen , JR Hibblen , J Hintikka , K Haatainen , K Honkalampi & K Viinamaki (2001) Fish consumption, depression, and suicidality in a general population. Arch Gen Psychiatry 58, 512–513.
42 A Tanskanen , JR Hibbeln & J Tuomilehto (2001) Fish consumption and depressive symptoms in the general population in Finland. Psychiatr Serv 52, 529–531.
44 R Hakkarainen , T Partonen , J Haukka , J Virtamo , D Albanes & J Lonnqvist (2004) Is dietary intake of omega-3 fatty acids associated with depression? Am J Psychiatry 161, 567–569.
45 FN Jacka , JA Pasco , MJ Henry , MA Kotowicz , GC Nicholson & M Berk (2004) Dietary omega-3 fatty acids and depression in a community sample. Nutr Neurosci 7, 101–106.
46 S Suzuki , T Akechi , M Kobayashi , K Taniguchi , K Goto , S Sasaki , S Tsugane , Y Nishiwaki , H Miyaoka & Y Uchitomi (2004) Daily omega-3 fatty acid intake and depression in Japanese patients with newly diagnosed lung cancer. Br J Cancer 90, 787–793.
48 P Barberger-Gateau , MA Jutand , L Letenneur , S Larrieu , B Tavernier & Berr C for the 3C Study Group (2005) Correlates of regular fish consumption in French elderly community dwellers: data from the Three-City study. Eur J Clin Nutr 59, 817–825.
50 KM Appleton , TJ Peters , RC Hayward , SV Heatherley , SA McNaughton , PJ Rogers , D Gunnell , AR Ness & D Kessler (2007) Depressed mood and n-3 polyunsaturated fatty acid intake from fish: non-linear or confounded association? Soc Psychiatry Psychiatr Epidemiol 42, 100–104.
51 KM Appleton , JV Woodside , JWG Yarnell , . (2007) Depressed mood and dietary fish intake: direct relationship or indirect relationship as a result of diet and lifestyle? J Affect Disord 104, 217–223.
52 BE Rodda , MC Miller & JG Bruhn (1971) Prediction of anxiety and depression patterns among coronary patients using a Markov Process Analysis. Comp Behav Sci 16, 482–489.
54 JE Ware & CD Sherbourne (1992) The MOS36-item short form health survey (SF-36). Conceptual framework and item selection. Med Care 30, 473–483.
55 AS Zigmond & RP Snaith (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67, 361–370.
56 A Winokur , DF Winokur , K Rickels & DS Cox (1984) Symptoms of emotional distress in a family planning service: stability over a four-week period. Br J Psychiatry 144, 395–399.
58 JL Cox , JM Holden & R Sagovsky (1987) Detection of postnatal depression development of the 10-item Edinburgh Postnatal Depression Scale. Br J Psychiatry 150, 782–786.
61 AMA Fehily , OAM Bowey , FR Ellis & BW Meade (1981) Plasma and erythrocyte membrane long chain polyunsaturated fatty acids in endogenous depression. Neurochem Int 3, 37–42.
62 M Maes , R Smith , A Christophe , P Cosyns , R Desnyder & H Meltzer (1996) Fatty acid composition in major depression: decreased ω3 fractions in cholesterol esters and increased C20:4ω6/C20:5ω3 ratio in cholesterol esters and phospholipids. J Affect Disord 38, 35–46.
63 M Peet , B Murphy , J Shay & D Horrobin (1998) Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients. Biol Psychiatry 43, 315–319.
64 R Edwards , M Peet , J Shay & D Horrobin (1998) Depletion of docosahexaenoic acid in red blood cell membranes of depressive patients. Biochem Soc Trans 26, S142.
65 M Maes , A Christophe , J Delanghe , C Altamura , H Neels & HY Meltzer (1999) Lowered omega-3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients. Psychiatry Res 85, 275–291.
70 SR De Vriese , AB Christophe & M Maes (2003) Lowered serum n-3 polyunsaturated fatty acid (PUFA) levels predict the occurrence of postpartum depression: further evidence that lowered n-PUFAs are related to major depression. Life Sci 73, 3181–3187.
71 J Assies , A Lok , CL Bockting , GJ Weverling , R Lieverse , I Visser , NGGM Abeling , M Duran & AH Schene (2004) Fatty acids and homocysteine levels in patients with recurrent depression: an explorative study. Prostaglandins Leukot Essent Fatty Acids 70, 349–356.
72 RK McNamara , CG Hahn , R Jandacek , T Rider , P Tso , KE Stanford & NM Richtand (2007) Selective deficits in the omega-3 fatty acid docosahexaenoic acid in the postmortem orbitofrontal cortex of patients with major depressive disorder. Biol Psychiatry 62, 17–24.
73 G Mamalakis , M Tornaritis & A Kafatos (2002) Depression and adipose essential polyunsaturated fatty acids. Prostaglandins Leukot Essent Fatty Acids 67, 311–318.
74 G Mamalakis , M Kiriakakis , G Tsibinos & A Kafatos (2004) Depression and adipose polyunsaturated fatty acids in an adolescent group. Prostaglandins Leukot Essent Fatty Acids 71, 289–294.
75 M Kobayakawa , S Yamawaki , K Hamazaki , T Akechi , M Inagaki & Y Uchitomi (2005) Levels of omega-3 fatty acid in serum phospholipids and depression in patients with lung cancer. Br J Cancer 93, 1329–1333.
76 G Mamalakis , E Jansen , H Cremers , M Kiriakakis , G Tsibinos & A Kafatos (2006) Depression and adipose and serum cholesteryl ester polyunsaturated fatty acids in the survivors of the seven countries study population of Crete. Eur J Clin Nutr 60, 1016–1023.
78 JC Browne , KM Scott & KM Silvers (2006) Fish consumption in pregnancy and omega-3 status after birth are not associated with postnatal depression. J Affect Disord 90, 131–139.
79 M Huan , K Hamazaki , Y Sun , M Itomura , H Liu , W Kang , S Watanabe , K Terasawa & T Hamazaki (2004) Suicide attemtpt and n-3 fatty acid levels in red blood cells: a case control study in China. Biol Psychiatry 56, 490–496.
80 CC Chiu , SY Huang , KP Su , ML Lu , MC Huang , CC Chen & WW Shen (2003) Polyunsaturated fatty acid deficit in patients with bipolar mania. Eur Neuropsychopharmacol 13, 99–103.
81 PK Ranjekar , A Hinge , MV Hegde , M Ghate , A Kale , S Sitasawad , UV Wagh , VB Debsikdar & SP Mahadik (2003) Decreased antioxidant enzymes and membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patients. Psychiatry Res 121, 109–122.
82 MR Garland , B Hallahan , M McNamara , PA Carney , H Grimes , JR Hibbeln , A Harkin & RM Conroy (2007) Lipids and essential fatty acids in patients presenting with self-harm. Br J Psychiatry 190, 112–117.
83 H Kaiya , DF Horrobin , MS Manku & N Morse-Fisher (1991) Essential and other fatty acids in plasma in schizophrenics and normal individuals from Japan. Biol Psychiatry 30, 357–362.
84 JT Biggs , LT Wylie & VE Ziegler (1978) Validity of the Zung self-rating depression scale. Br J Psychiatry 132, 381–385.
87 G Mamalakis , M Kiriakakis , G Tsibinos , C Hatzis , S Flouri , C Mantzoros & A Kafatos (2006) Depression and serum adiponectin and adipose omega-3 and omega-6 fatty acids in adolescents. Pharmacol Biochem Behav 85, 474–479.
88 G Mamalakis , N Kalogeropoulos , N Andikopoulos , C Hatzis , D Kromhout , J Moschandrea & A Kafatos (2006) Depression and long chain n-3 fatty acids in adipose tissue in adults from Crete. Eur J Clin Nutr 60, 882–888.
89 AM Llorente , CL Jensen , RG Voigt , JK Fraley , MC Berretta & WC Heird (2003) Effect of maternal docosahexaenoic acid supplementation on postpartum depression and information processing. Am J Obstet Gynecol 188, 1348–1353.
90 TOC Kilkens , A Honig , M Maes , R Lousberg & R-JM Brummer (2004) Fatty acid profile and affective dysregulation in irritable bowel syndrome. Lipids 39, 425–431.
91 J Assies , R Lieverse , P Vreken , RJA Wanders , PMJA Dingemans & DH Linszen (2001) Significantly reduced docosahexaenoic and docosapentaenoic acid concentrations in erythrocyte membranes from schizophrenic patients compared with a carefully matched control group. Biol Psychiatry 49, 510–522.
92 ME Sublette , JR Hibbeln , H Galfalvy , MA Oquendo & JJ Mann (2006) Omega-3 polyunsaturated essential fatty acid status as a predictor of future suicide risk. Am J Psychiatry 163, 1100–1102.
93 M Hamilton (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23, 56–62.
94 G Parker , T Hilton , J Bains & D Hadzi-Pavlovic (2002) Cognitive-based measures screening for depression in the medically ill: the DMI-10 and the DMI-18. Acta Psychiatr Scand 105, 419–426.
96 SA Montgomery & M Asberg (1979) A new depression scale designed to be sensitive to change. Br J Psychiatry 134, 382–389.
99 MP Freeman , JR Hibbeln , KL Wisner , BH Brumbach , M Watchman & AJ Gelenberg (2006) Randomized dose-ranging pilot trial of omega-3 fatty acids for postpartum depression. Acta Psychiatr Scand 113, 31–35.
100 Y Osher , Y Bersudsky & RH Belmaker (2005) Omega-3 eicosapentaenoic acid in bipolar depression: report of a small open-label study. J Clin Psychiatry 66, 726–729.
102 K Sagduyu , ME Dokucu , BA Eddy , G Craigen , CF Baldassano & A Yildiz (2005) Omega-3 fatty acids decreased irritability of patients with bipolar disorder in an add-on, open label study. Nutr J 4, 6.
104 BK Puri , AJ Richardson & DF Horrobin (2002) Eicosapentaenoic acid in treatment-resistant depression. Arch Gen Psychiatry 59, 91–92.
105 LB Marangell , JM Martinez , HA Zboyan , H Chong & LJ Puryear (2004) Omega-3 fatty acids for the prevention of postpartum depression: negative data from a preliminary open-label pilot study. Depress Anx 19, 20–23.
107 B Nemets , Z Stahl & RH Belmaker (2002) Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. Am J Psychiatry 159, 477–479.
108 MB Peet & DF Horrobin (2002) A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs. Arch Gen Psychiatry 59, 913–919.
109 LB Marangell , JM Martinez , HA Zboyan , B Kertz , HF Seung Kim & LJ Puryear (2003) A double-blind, placebo-controlled study of the omega-3 fatty acid docosahexaenoic acid in the treatment of major depression. Am J Psychiatry 160, 996–998.
110 K-P Su , S-Y Huang , C-C Chiu & WW Shen (2003) Omega-3 fatty acids in major depressive disorder – a preliminary double-blind placebo-controlled trial. Eur Neuropsychopharmacol 13, 267–271.
111 KM Silvers , CC Woolley , FC Hamilton , PM Watts & RA Watson (2005) Randomised double-blind placebo-controlled trial of fish oil in the treatment of depression. Prostaglandins Leukot Essent Fatty Acids 72, 211–218.
112 H Nemets , B Nemets , A Apter , Z Bracha & RH Belmaker (2006) Omega-3 treatment of children's depression: a controlled, double-blind pilot study. Am J Psychiatry 163, 1098–1100.
113 BFS Grenyer , T Crowe , B Meyer , AJ Owen , EM Grigonis , P Caputi & PRC Howe (2007) Fish oil supplementation in the treatment of major depression: a randomised double-blind placebo-controlled trial. Prog Neuropsychopharmacol Biol Psychiatry 31, 1393–1396.
114 AL Stoll , WE Severus , MP Freeman , S Rueter , HA Zboyan , E Diamond , KK Cress & LB Marangell (1999) Omega-3 fatty acids in bipolar disorder – a preliminary double-blind, placebo-controlled trial. Arch Gen Psychiatry 56, 407–412.
115 S Frangou , M Lewis & P McCrone (2006) Efficacy of ethyl-eicosapentaenoic acid in bipolar depression: randomised double-blind placebo-controlled study. Br J Psychiatry 188, 46–50.
116 PE Keck Jr, J Mintz , SL McElroy , . (2006) Double-blind, randomized, placebo-controlled trials of ethyl-eicosapentanoate in the treatment of bipolar depression and rapid cycling bipolar disorder. Biol Psychiatry 60, 1020–1022.
117 AR Ness , JEJ Gallacher , PD Bennett , DJ Gunnell , PJ Rogers , D Kessler & ML Burr (2003) Advice to eat fish and mood: a randomised controlled trial in men with angina. Nutr Neurosci 6, 63–65.
118 G Fontani , F Corradeschi , A Felici , F Alfatti , R Bugarini , AI Fiaschi , D Cerretani , G Montorfani , AM Rizzo & B Berra (2005) Blood profiles, body fat and mood state in healthy subjects on different diets supplemented with omega-3 polyunsaturated fatty acids. Eur J Clin Invest 35, 499–507.
120 PO Behan , WMH Behan & D Horrobin (1990) Effect of high doses of essential fatty acids on the postviral fatigue syndrome. Acta Neurol Scand 82, 209–216.
121 G Warren , M McKendrick & M Peet (1999) The role of essential fatty acids in chronic fatigue syndrome. Acta Neurol Scand 99, 112–116.
123 M Peet & DF Horrobin in association with the E-E Multicentre Study Group (2002) A dose-ranging exploratory study of the effects of ethyl-eicosapentaenoate in patients with persistent schizophrenic symptoms. J Psychiatric Res 36, 7–18.
124 MC Zanarini & MD Frankenburg (2003) Omega-3 fatty acid treatment of women with borderline personality disorder: a double-blind, placebo-controlled pilot study. Am J Psychiatry 160, 167–169.
126 B Hallahan , JR Hibbeln , JM Davis & MR Garland (2007) Omega-3 fatty acid supplementation in patients with recurrent self-harm. Single-centre double-blind randomised controlled trial. Br J Psychiatry 190, 118–122.
131 RC Young , JT Biggs , VE Ziegler & DA Meyer (1978) A rating scale for mania: reliability, validity, and sensitivity. Br J Psychiatry 133, 429–435.
133 MK Spearing , RM Post , GS Leverich , D Brandt & W Nolen (1997) Modification of the Clinical Global Impressions (CGI) scale for use in bipolar illness (BP): the CGI-BP. Psychiatry Res 73, 159–171.
139 MP Freeman , JR Hibblen , KL Wisner , . (2006) Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. J Clin Psychiatry 67, 1954–1967.
140 P-Y Lin & K-P Su (2007) A meta-analytic review of double-blind, placebo-controlled trials of anti-depressant efficacy of omega-3 fatty acids. J Clin Psychiatry 68, 1056–1061.
143 P Green , H Hermesh , A Monselise , S Marom , G Presburger & A Weizman (2006) Red cell membrane omega-3 fatty acids are decreased in nondepressed patients with social anxiety disorder. Eur Neuropsychopharmacol 16, 107–113.
144 S Yehuda , S Rabinovitz & DI Mostofsky (2005) Mixture of essential fatty acids lowers test anxiety. Nutr Neurosci 8, 265–267.
145 GP Holmes , JE Kaplan , NM Gantz , . (1988) Chronic fatigue syndrome: a working definition. Ann Int Med 108, 387–389.
147 BK Puri (2004) The use of eicosapentaenoic acid in the treatment of chronic fatigue syndrome. Prostaglandins Leukot Essent Fatty Acids 70, 399–401.
149 C Iribarren , JH Markovitz , DR Jacobs Jr, PJ Schreiner , M Daviglus & JR Hibbeln (2004) Dietary intake of n-3, n-6 fatty acids and fish: relationship with hostility in young adults – the CARDIA study. Eur J Clin Nutr 58, 24–31.
150 L Buydens-Branchey , M Branchey , DL McMakin & JR Hibbeln (2003) Polyunsaturated fatty acid status and aggression in cocaine addicts. Drug Alcohol Depend 71, 319–323.
151 JC Umhau , KM Dauphinais , SH Patel , DA Nahrwold , JR Hibbeln & RR Rawlings (2006) The relationship between folate and docosahexaenoic acid in men. Eur J Clin Nutr 60, 352–357.
152 ME Virkkunen , DF Horrobin , DK Jenkins & MS Manku (1987) Plasma phospholipid essential fatty acids and prostaglandins in alcoholic, habitually violent and impulsive offenders. Biol Psychiatry 22, 1087–1096.
153 T Hamazaki , S Sawazaki , M Itomura , E Asaoka , Y Nagao , N Nishimura , K Yazawa , T Kuwamori & M Kobayashi (1996) The effect of docosahexaenoic acid on aggression in young adults: a placebo-controlled double-blind study. J Clin Invest 97, 1129–1133.
154 T Hamazaki , S Sawazaki , Y Nagao , T Kuwamori , K Yazawa , Y Mizushima & M Kobayashi (1998) Docosahexaenoic acid does not affect aggression of normal volunteers under non-stressful conditions: a randomized, placebo-controlled, double-blind study. Lipids 33, 663–667.
155 T Hamazaki , A Thienprasert , K Kheovichai , S Samuhaseneetoo , T Nagasawa & S Watanabe (2002) The effect of docosahexaenoic acid on aggression in elderly Thai subjects – a placebo-controlled double-blind study. Nutr Neurosci 5, 37–41.
156 M Itomura , K Hamazaki , S Sawazaki , M Kobayashi , K Terasawa , S Watanabe & T Hamazaki (2005) The effect of fish oil on physical aggression in schoolchildren – a randomized, double-blind, placebo-controlled trial. J Nutr Biochem 16, 163–171.
157 S Hirayama , T Hamazaki & K Terasawa (2004) Effect of docosahexaenoic acid-containing food administration on symptoms of attention-deficit/hyperactivity disorder – a placebo-controlled double-blind study. Eur J Clin Nutr 58, 467–473.
158 GP Amminger , GE Berger , MR Schafer , C Klier , MH Friedrich & M Feucht (2007) Omega-3 fatty acids supplementation in children with autism: a double-blind randomized, placebo-controlled pilot study. Biol Psychiatry 61, 551–553.
159 L Buydens-Branchey & M Branchey (2006) n-3 Polyunsaturated fatty acids decrease anxiety feelings in a population of substance abusers. J Clin Psychopharmacol 26, 661–665.
160 CB Gesch , SM Hammond , SE Hampson , A Eves & MJ Crowder (2002) Influence of supplementary vitamins, minerals and essential fatty acids on the antisocial behaviour of young adult prisoners: randomised placebo-controlled trial. Br J Psychiatry 181, 22–28.
164 AH Buss & M Perry (1992) The aggression questionnaire. J Pers Soc Psychol 63, 452–459.
167 JR Hibbeln , JM Davis , C Steer , P Emmett , I Rogers , C Williams & J Golding (2007) Maternal seafood consumption in pregnancy and neurodevelopmental outcomes in childhood (ALSPAC study): an observational cohort. Lancet 369, 578–585.
168 EA Mitchell , MG Aman , SH Turbott & M Manku (1987) Clinical characteristics and serum essential fatty acids levels in hyperactive children. Clin Pediatrics 26, 406–411.
170 L Stevens , W Zhang , L Peck , T Kuczek , N Grevstad , A Mahon , SS Zentall , LE Arnold & JR Burgess (2003) EFA supplementation in children with inattention, hyperactivity and other disruptive behaviours. Lipids 38, 1007–1021.
172 CJ Antalis , LJ Stevens , M Campbell , R Pazdro , K Ericson & JR Burgess (2006) Omega-3 fatty acid status in attention-deficit/hyperactivity disorder. Prostaglandins Leukot Essent Fatty Acids 75, 299–308.
173 LJ Stevens , SS Zentall , ML Abate , T Kuczek & JR Burgess (1996) Omega-3 fatty acids in boys with behavior, learning and health problems. Physiol Behav 59, 915–920.
174 K Joshi , S Lad , M Kale , B Patwardhan , SP Mahadik , B Patni , A Chaudhary , S Bhave & A Pandit (2006) Supplementation with flax oil and vitamin C improves the outcome of attention deficit hyperactivity disorder (ADHD). Prostaglandins Leukot Essent Fatty Acids 74, 17–21.
175 RG Voigt , AM Llorente , CL Jensen , JK Fraley , MC Berretta & WC Heird (2001) A randomized double-blind, placebo-controlled trial of docosahexaenoic acid supplementation in children with attention-deficit/hyperactivity disorder. J Pediatrics 139, 189–196.
186 DM Dougherty , DM Marsh & CW Mathias (2002) Immediate and delayed memory tasks: a computerized behavioral measure of memory, attention and impulsivity. Behav Res Methods, Insturm Comput 34, 391–398.
188 M Strassnig , J Singh Brar & R Ganguli (2005) Dietary fatty acid and antioxidant intake in community-dwelling patients suffering from schizophrenia. Schizophr Res 76, 343–351.
189 FO Obi & EAC Nwanze (1979) Fatty acid profiles in mental disease: lineolate variations in schizophrenia. J Neurobiol Sci 43, 447–454.
190 DF Horrobin , MS Manku , N Morse-Fisher , KS Vaddadi , P Courtney , IM Glen , E Glen , M Spellman & C Bates (1989) Essential fatty acids in plasma phospholipids in schizophrenics. Biol Psychiatry 25, 562–568.
191 JK Yao , DP van Kammen & JA Welker (1994) Red blood cell membrane dynamics in schizophrenia. II. Fatty acid composition. Schizophr Res 13, 217–226.
192 M Peet , J Laugharne , N Rangarajan , D Horrobin & G Reynolds (1995) Depleted red cell membrane essential fatty acids in drug-treated schizophrenic patients. J Psychiatr Res 29, 227–232.
194 MM Khan , DR Evans , V Gunna , RE Scheffer , VV Parikh & SP Mahadik (2002) Reduced erythrocyte membrane essential fatty acids and increased lipid peroxides in schizophrenia at the never-medicated first-episode of psychosis and after years of treatment with anti-psychotics. Schizophr Res 58, 1–10.
195 M Landen , P Davidsson , CG Gottfries , JE Mansson & K Blennow (2002) Reduction of the synaptophysin level but normal levels of glycerophospholipids in the gyrus cinguli in schizophrenia. Schizophr Res 55, 83–88.
196 M Arvindakshan , M Ghate , PK Ranjekar , DR Evans & SP Mahadik (2003) Supplementation with a combination of omega-3 fatty acids and antioxidants (vitamins E and C) improves the outcome of schizophrenia. Schizophr Res 62, 195–204.
197 DR Evans , VV Parikh , MM Khan , C Coussons , PF Buckley & SP Mahadik (2003) Red blood cell membrane essential fatty acid metabolism in early psychotic patients following antipsychotic drug treatment. Prostaglandins Leukot Essent Fatty Acids 69, 393–399.
198 M Peet , S Shah , K Selvam & CN Ramchand (2004) Polyunsaturated fatty acid levels in red cell membranes of unmedicated schizophrenic patients. World J Biol Psychiatry 5, 92–99.
200 RFJ Kemperman , M Veurink , T van der Wal , H Knegtering , R Bruggeman , MR Fokkema , IP Kema , J Korf & FAJ Muskiet (2006) Low essential fatty acid and B-vitamin status in a subgroup of patients with schizophrenia and its response to dietary supplementation. Prostaglandins Leukot Essent Fatty Acids 74, 75–85.
201 RK McNamara , R Jandacek , T Rider , P Tso , CG Hahn , NM Richtand & KE Stanford (2007) Abnormalities in the fatty acid composition of the postmortem orbitofrontal cortex of schizophrenic patients: gender differences and partial normalization with antipsychotic medications. Schizophr Res 91, 37–50.
203 AJ Richardson , E Cyhlarova & MA Ross (2003) Omega-3 and omega-6 fatty acid concentrations in red blood cell membranes relate to schizotypal traits in healthy adults. Prostaglandins Leukot Essent Fatty Acids 69, 461–466.
204 S Shah , GK Vankar , SD Telang , CN Ramchand & M Peet (1998) Eicosapentaenoic acid (EPA) as an adjunct in the treatment of schizophrenia. Schizophr Res 29, 158.
206 BK Puri & AJ Richardson (1998) Sustained remission of positive and negative symptoms of schizophrenia following treatment with eicosapentaenoic acid. Arch Gen Psychiatry 55, 188–189.
207 M Peet , J Brind , CN Ramchand , S Shah & GK Vankar (2001) Two double-blind placebo-controlled pilot studies of eicosapentaenoic acid in the treatment of schizophrenia. Schizophr Res 49, 243–251.
209 S Vancassel , G Durand , C Barthelemy , B Lejeune , J Martineau , D Guilloteau , C Andres & S Chalon (2001) Plasma fatty acid levels in autistic children. Prostaglandins Leukot Essent Fatty Acids 65, 1–7.
210 JG Bell , EE MacKinley , JR Dick , DJ MacDonald , RM Boyle & ACA Glen (2004) Essential fatty acids and phospholipase A2 in autistic spectrum disorders. Prostaglandins Leukot Essent Fatty Acids 71, 201–204.
211 SM Johnson & E Hollander (2003) Evidence that eicosapentanoic acid is effective in treating autism. J Clin Psychiatry 64, 848–849.
212 MR DiMatteo , HS Lepper & TW Croghan (2000) Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 160, 2101–2107.
215 DE Mills , YS Huang , M Nane & JP Poisson (1994) Psychosocial stress, catecholamines, and essential fatty acid metabolism in rats. Soc Exp Biol Med 205, 56–61.
216 RR Brenner (2003) Hormonal modulation of Δ6 and Δ5 desaturases: case of diabetes. Prostaglandins Leukot Essent Fatty Acids 68, 151–162.
217 JR Hibbeln , KK Makino , CE Martin , F Dickerson , J Boronow & WS Fenton (2003) Smoking, gender, and dietary influences on erythrocyte essential fatty acid composition among patients with schizophrenia or schizoaffective disorder. Biol Psychiatry 53, 431–441.
218 RD Reddy & JK Yao (2003) Environmental factors and membrane polyunsaturated fatty acids in schizophrenia. Prostaglandins Leukot Essent Fatty Acids 69, 385–391.
219 CI Hasanah , UA Khan , M Musalmah & SM Razali (1997) Reduced red-cell folate in mania. J Affect Disord 46, 95–99.
220 CM Stoney & TO Engebretson (2000) Plasma homocysteine concentrations are positively associated with hostility and anger. Life Sci 66, 2267–2275.
221 P Durand , M Prost & D Blache (1996) Pro-thrombotic effects of a folic acid deficient diet in rat platelets and macrophages related to elevated homocysteine and decreased n-3 polyunsaturated fatty acids. Atherosclerosis 121, 231–243.
223 M Bekaroglu , Y Aslan , Y Gedik , O Deger , H Mocan , E Erduran & C Karahan (1996) Relationships between serum free fatty acids and zinc, and attention deficit hyperactivity disorder: a research note. J Child Psychol Psychiatry 37, 225–227.
225 LE Arnold , H Bozzolo , J Hollway , A Cook , RA DiSilvestro , DR Bozzolo , L Crowl , Y Ramadan & C Williams (2005) Serum zinc correlates with parent- and teacher-rated inattention in children with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 15, 628–636.
226 S Akhondzadeh , M-R Mohammadi & M Khademi (2004) Zinc sulphate as an adjunct to methylphenidate for the treatment of attention deficit hyperactivity disorder in children: a double blind and randomized trial (ISRCTN64132371). BMC Psychiatry 4, 9.
228 LE Arnold & RA DiSilvestro (2005) Zinc in attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 15, 619–627.
229 C Bolton-Smith , M Woodward & R Tavendale (1997) Evidence for age related differences in the fatty acid composition of human adipose tissue, independent of diet. Eur J Clin Nutr 51, 619–624.
231 J Sontrop & MK Campbell (2005) ω-3 Polyunsaturated fatty acids and depression: a review of the evidence and a methodological critique. Prev Med 42, 4–13.
232 F Visioli , P Rise , MC Barassi , F Marangoni & C Galli (2003) Dietary intake of fish vs. formulations leads to higher plasma concentrations of n-3 fatty acids. Lipids 38, 415–418.
234 DF Horrobin , K Jenkins , CN Bennett & WW Christie (2002) Eicosapentaenoic acid and arachidonic acid: collaboration and not antagonism is the key to biological understanding. Prostaglandins Leukot Essent Fatty Acids 66, 83–90.
235 I Kirsch , BJ Deacon , TB Huedo-Medina , A Scoboria , TJ Moore & BT Johnson (2008) Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PLoS Med 5, 260–267.
236 AL Stoll , KE Damico , BP Daly , WE Severus & LB Marangell (2001) Methodological considerations in clinical studies of omega 3 fatty acids in major depression and bipolar disorder. World Rev Nutr Diet 88, 58–67.
237 BK Puri & AK Richardson (2000) The effects of olive oil on ω3 fatty acids and mood disorders. Arch Gen Psychiatry 57, 715.
239 CU Pae , HS Yu , JJ Kim , CU Lee , SJ Lee , TY Jun , C Lee & IH Paik (2004) Quinone oxidoreductase (NQO1) gene polymorphism (609C/T) may be associated with tardive dyskinesia, but not with the development of schizophrenia. Int J Neuropsychopharmcol 7, 495–500.
240 BM Ross (2007) Omega-3 fatty acid deficiency in major depressive disorder is caused by the interaction between diet and a genetically determined abnormality in phospholipid metabolism. Med Hypotheses 68, 515–524.
242 M Peet (2003) Eicosapentaenoic acid in the treatment of schizophrenia and depression: rationale and preliminary double-blind clinical trial results. Prostaglandins Leukot Essent Fatty Acids 69, 477–485.
245 ACP Van Strater & PF Bouly (2006) Omega-3 fatty acids and mood disorders. Am J Psychiatry 163, 2018.
246 G Kinrys (2000) Hypomania associated with ω3 fatty acids. Arch Gen Psychiatry 57, 715–716.